C-MYC Targets in the Pathogenesis of Human Cancer
C-MYC Targets in the Pathogenesis of Human Cancer
批准号:
7071170
负责人:
CHI V. DANG
金额:
$39.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-01 至 2010-05-31
关键词:
acetylationapoptosiscell cycle proteinschromatin immunoprecipitationgene induction /repressiongenetically modified animalshistoneslaboratory mousemethylationmicroarray technologymolecular oncologyneoplasm /cancer geneticsneoplastic transformationprotooncogeneserial analysis of gene expressiontranscription factor
中文摘要
描述(由申请人提供):c-Myc致癌转录因子通过调控基因表达在许多人类癌症中起关键作用。尽管Myc调控基因表达的方式已经得到了更好的定义,但Myc调控的基因群只是从各种不同的实验方法中出现的。通过使用减法克隆、DMA微阵列分析、SAGE、ChIP和基因组标记方法,Myc靶基因的大型数据集补充了个体Myc靶基因及其功能含义的研究。我们在Myc靶基因数据库(www.myccancergene.org)中对这些数据进行了注释。Myc靶基因似乎以一种依赖于环境的方式对Myc作出反应。特别是,其他转录因子如何与Myc协同调节这些基因以及细胞类型特异性作用需要进一步研究。为了充分了解肿瘤中Myc生理功能和不受调节的Myc功能之间的差异,挑战在于描述Myc应答转录组如何影响Myc诱导的各种表型。具体来说,我们假设在生理条件下,Myc与特定的转录因子合作促进基因表达,而在病理性的Myc高表达下,Myc能够诱导一组不同的异位Myc靶基因,这些基因有助于肿瘤的发生。为了达到了解Myc在人类癌症中的长期目标,我们设定了以下具体目标:确定生理和病理Myc靶基因网络的差异,并确定编码转录因子和其他关键信号转导蛋白的下游靶枢纽。目标2。维护和完善Myc靶基因数据库。目标3。鉴定与Myc协同调控下游靶标的转录因子。目标4。确定Myc与缺氧诱导转录因子HIF1协同调节对肿瘤生存至关重要的缺氧反应基因(如编码糖酵解酶的基因)的分子机制。
英文摘要
DESCRIPTION (provided by applicant): The c-Myc oncogenic transcription factor plays a key role in many human cancers through the regulation of gene expression. Although how Myc regulates gene expression is better defined, the groups of genes that Myc regulate are just emerging from a variety of different experimental approaches. Studies of individual Myc target genes and their functional implications are now complemented by large datasets of Myc target genes through the use of subtraction cloning, DMA microarray analysis, SAGE, ChIP, and genome marking methods. We have annotated these data in a Myc Target Gene database (www.myccancergene.org). Myc target genes appear to respond to Myc in a context dependent manner. In particular, how other transcription factors collaborate with Myc to regulate these genes as well as cell type specific effects need further study. To fully appreciate the differences between physiological Myc function and deregulated Myc function in tumors, the challenge is to delineate how the Myc-responsive transcriptomes influence the various phenotypes induced by Myc. Specifically, we hypothesize that under physiological conditions, Myc cooperates with specific transcription factors to promote gene expression, while under pathological, high Myc expression, Myc is able to induced a distinct set of ectopic Myc target genes that contribute to tumorigenesis. To reach our long-term goal of understanding Myc in human cancers we set the following Specific Aims: Aim 1. To determine differences between the physiological and pathological Myc target gene networks and identify downstream target hubs that encode transcription factors and other key signal transduction proteins. Aim 2. To maintain and improve the Myc target gene database. Aim 3. To identify transcription factors that cooperate with Myc in regulating downstream targets. Aim 4. To determine the molecular mechanisms by which Myc collaborates with the hypoxia inducible transcription factor, HIF1, in regulating hypoxia-responsive genes vital for tumor survival such as those encoding glycolytic enzymes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10205608
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10396617
-
项目类别:
-
资助金额:$10.35万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10728412
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10623158
-
项目类别:
-
资助金额:$54.47万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6474169
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6528030
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6651086
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
FASEB conference on Hematological Malignancies
-
批准号:6359970
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8710658
-
项目类别:
-
资助金额:$1.25万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9131243
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8402161
-
项目类别:
-
资助金额:$721.69万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8998395
-
项目类别:
-
资助金额:$797.55万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
DEVELOPMENTAL FUNDS (Core 002)
-
批准号:8998398
-
项目类别:
-
资助金额:$99.53万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
PLANNING AND EVALUATION (Core 001)
-
批准号:8998397
-
项目类别:
-
资助金额:$5.27万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9338556
-
项目类别:
-
资助金额:$50.0万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8789009
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8300800
-
项目类别:
-
资助金额:$772.51万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9378876
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
C-MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:3201669
-
项目类别:
-
资助金额:$23.34万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
C-MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:3201668
-
项目类别:
-
资助金额:$22.4万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: